Figure 7 shows the sensitivity of two ADCP subtypes to six anticancer drugs (AZD8055, A.443654, AMG.706, AKT.inhibitor.VIII, ABT.888, ATRA). Results showed that the IC50 level of group2 was higher compared to group1 (Figure 7A–7F), and small molecule drugs with therapeutic effects on BC could be found according to the results of drug sensitivity. Three-dimensional structural tomography of AZD8055, A.443654, AMG.706, AKT.inhibitor.VIII, ABT.888 and ATRA was found in PubChem (Figure 7G). Here, AKT1 is linked to breast cancer.